Vagus nerve stimulation as a potential modulator of periictal psychotic episodes: A report of four cases.

Drug-resistant epilepsy Periictal psychotic episodes Positron emission tomography Psychosis Vagus nerve stimulation

Journal

Epilepsy & behavior reports
ISSN: 2589-9864
Titre abrégé: Epilepsy Behav Rep
Pays: United States
ID NLM: 101750909

Informations de publication

Date de publication:
2021
Historique:
received: 31 10 2020
revised: 12 01 2021
accepted: 21 01 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 6 3 2021
Statut: epublish

Résumé

Drug resistant epilepsy (DRE) has been associated with a high incidence of psychotic disorders. Patients can develop psychosis after starting a new antiseizure medication, after undergoing resective surgery, or after implantation of a vagus nerve stimulation (VNS) system. The aim of this study was to investigate the modulation effect of VNS on psychotic episodes in DRE patients with a pre-existing history of periictal psychotic episodes (PPE). We retrospectively report the outcome of four patients from a single tertiary center with PPE prior to implantation. None of the implanted patients developed

Identifiants

pubmed: 33665601
doi: 10.1016/j.ebr.2021.100434
pii: S2589-9864(21)00008-3
pmc: PMC7905174
doi:

Types de publication

Case Reports

Langues

eng

Pagination

100434

Informations de copyright

© 2021 The Author(s).

Références

Neurotherapeutics. 2018 Oct;15(4):1082-1092
pubmed: 30066084
Adv Neurol. 1991;55:127-42
pubmed: 2003402
Epilepsy Behav. 2018 Mar;80:365-369
pubmed: 29415871
EBioMedicine. 2020 Jan;51:102568
pubmed: 31927311
Psychiatry Res. 2016 Nov 30;245:333-339
pubmed: 27573056
Br J Psychiatry. 1988 Feb;152:246-52
pubmed: 3167343
Mol Psychiatry. 2018 Apr;23(4):943-951
pubmed: 28373685
Acta Neurol Scand. 2003 Feb;107(2):117-21
pubmed: 12580861
Front Syst Neurosci. 2016 Dec 27;10:104
pubmed: 28082874
Int Rev Psychiatry. 2017 Apr;29(2):178-190
pubmed: 28523977
Epilepsy Behav. 2002 Aug;3(4):303-308
pubmed: 12609326
J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):611-617
pubmed: 29275328
Epilepsy Behav. 2001 Oct;2(5):466-472
pubmed: 12609285
J Neurosci. 2014 Jul 9;34(28):9261-7
pubmed: 25009259
Acta Neurol Belg. 2003 Sep;103(3):170-5
pubmed: 14626698
BMC Psychiatry. 2014 Mar 13;14:75
pubmed: 24625201
Epilepsy Behav Case Rep. 2019 Jan 27;11:81-83
pubmed: 30788214
J Neurol Neurosurg Psychiatry. 1992 Feb;55(2):89-91
pubmed: 1538232
J Neurol Neurosurg Psychiatry. 2000 Jan;68(1):100-1
pubmed: 10671113
Neurology. 2004 Mar 9;62(5):708-13
pubmed: 15007118
Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):589-600
pubmed: 26210303

Auteurs

Montse Alemany (M)

Neuro-Oncology Unit, Neurology Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Eva Real (E)

Epilepsy Unit, Psychiatry Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Núria Custal (N)

Epilepsy Unit, Psychiatry Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Jacint Sala-Padró (J)

Epilepsy Unit, Neurology Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Laura Rodríguez-Bel (L)

Institute of Image Diagnosis (IDI), PET Division, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Gerard Plans (G)

Epilepsy Unit, Neurosurgery Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Jaume Mora (J)

Institute of Image Diagnosis (IDI), SPECT division, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Mila Santurino (M)

Epilepsy Unit, Neurology Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Tim Vancamp (T)

e4Sci, Sabadell, Spain.

Mercè Falip (M)

Epilepsy Unit, Neurology Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Classifications MeSH